EyeGate Pharmaceuticals Inc
Biotechnology
Healthcare
EYEG
7.06M shares
NASDAQ US
traded
05 Nov 2021
open
1.99
52 week high
7.68
high
2.00
52 week low
1.48
low
1.92
growth
-43.64%
previous Close
1.98
P/E ratio
-6
market cap
25.49M
div yield
0
usd
Jun 2021
qoq
revenue
net incoming
-2.47M
4.32 %
eps
-0.35
5.41 %
eps surprise
16.01 %
net profit margin
-246929800 %
21401.00 %
operating incoming
-2.75M
-6.41 %
net change in cash
-2.95M
-154.33 %
cash on hand
3.66M
-44.58 %
cost of revenue
top top